Alteration of AMPK expression and/or activity is found in hematological malignancies such as CMML, and activation of the AMPK pathway appears to restore normal differentiation in some CMML patients [51]. The gene discussed is PRKAA1; the disease is chronic myelomonocytic leukemia.